Quilty in biopsy is associated with poor prognosis after heart transplantation

Transplant Immunology

Volumn 19, Issue 3-4, 2008, Pages 209-214

  Hiemann, Nicola Erika ^a   Knosalla, Christoph ^a   Wellnhofer, Ernst ^a   Lehmkuhl, Hans Brendan ^a   Hetzer, Roland ^a   Meyer, Rudolf ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Endomyocardial biopsy; Heart transplantation; Histology; Prognosis; Quilty

Indexed keywords

ACUTE GRAFT REJECTION; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY OBSTRUCTION; ENDOCARDIAL BIOPSY; ENDOCARDIUM; FEMALE; GRAFT FAILURE; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUILTY; RISK ASSESSMENT; VASCULAR DISEASE;

BIOPSY; CELL MOVEMENT; CORONARY ANGIOGRAPHY; ENDOCARDIUM; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOLOGY; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 48349134180     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.06.003     Document Type: Article

References (38)

1. Joshi A., Masek M.A., Brown Jr. B.W., Weiss L.M., and Billingham M.E. "Quilty "; revisited: a 10-year perspective. Hum Pathol 26 (1995) 547-557
2. Radio S.J., McManus B.M., Winters G.L., Kendall T.J., Wilson J.E., Costanzo-Nordin M.R., et al. Preferential endocardial residence of B-cells in the "Quilty effect "; of human heart allografts: immunohistochemical distinction from rejection. Mod Pathol 4 (1991) 654-660
3. Gopal S., Narasimhan U., Day J.D., Gao R., Kasper E.K., Chen C.L., et al. The Quilty lesion enigma: focal apoptosis/necrosis and lymphocyte subsets in human cardiac allografts. Pathol Int 48 (1998) 191-198
4. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720 Epub 2005 Jun 1720
5. Costanzo-Nordin M.R., Winters G.L., Fisher S.G., O'Sullivan J., Heroux A.L., Kao W., et al. Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens. J Heart Lung Transplant 12 (1993) 741-747
6. Chu K.E., Ho E.K., de la Torre L., Vasilescu E.R., and Marboe C.C. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation. Cardiovasc Pathol 14 (2005) 219-224
7. Smith R.N., Chang Y., Houser S., Dec G.W., and Grazette L. Higher frequency of high-grade rejections in cardiac allograft patients after Quilty B lesions or grade 2/4 rejections. Transplantation 73 (2002) 1928-1932
8. Yamani M.H., Ratliff N.B., Starling R.C., Tuzcu E.M., Yu Y., Cook D.J., et al. Quilty lesions are associated with increased expression of vitronectin receptor (alphavbeta3) and subsequent development of coronary vasculopathy. J Heart Lung Transplant 22 (2003) 687-690
9. Marboe C.C., Billingham M., Eisen H., Deng M.C., Baron H., Mehra M., et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 24 (2005) S219-226
10. Michaels P.J., Kobashigawa J., Laks H., Azarbal A., Espejo M.L., Chen L., et al. Differential expression of RANTES chemokine, TGF-beta, and leukocyte phenotype in acute cellular rejection and Quilty B lesions. J Heart Lung Transplant 20 (2001) 407-416
11. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 9 (1990) 587-593
12. Plaza D.M., Fernandez D., Builes M., Villegas A., and Garcia L.F. Cytokine gene polymorphisms in heart transplantation: association of low IL-10 production genotype with Quilty effect. J Heart Lung Transplant 22 (2003) 851-856
13. Di Carlo E., D'Antuono T., Contento S., Di Nicola M., Ballone E., and Sorrentino C. Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections. Am J Transplant 7 (2007) 201-210 Epub 2006 Oct 2025
14. Yun J.J., Whiting D., Fischbein M.P., Banerji A., Irie Y., Stein D., et al. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation 109 (2004) 932-937
15. Sturmhofel K., Brando C., Martinon F., Shevach E.M., and Coligan J.E. Antigen-independent, integrin-mediated T cell activation. J Immunol 154 (1995) 2104-2111
16. Chantranuwat C., Qiao J.H., Kobashigawa J., Hong L., Shintaku P., and Fishbein M.C. Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence. Appl Immunohistochem Mol Morphol 12 (2004) 166-171
17. Sharples L.D., Jackson C.H., Parameshwar J., Wallwork J., and Large S.R. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 76 (2003) 679-682
18. Aranda J.M., Pauly D.F., Kerensky R.A., Cleeton T.S., Walker T.C., Schofield R.S., et al. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experience. J Heart Lung Transplant 21 (2002) 860-866
19. Halle III A.A., DiSciascio G., Massin E.K., Wilson R.F., Johnson M.R., Sullivan H.J., Bourge R.C., Kleiman N.S., Miller L.W., Aversano T.R., et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 26 (1995) 120-128
20. Hiemann N.E., Meyer R., Wellnhofer E., and Hetzer R. Small vessel disease after heart transplantation: impact of immunological and non-immunological risk factors. Transplant Int 18 (2005) 908-914
21. Sattar H.A., Husain A.N., Kim A.Y., and Krausz T. The presence of a CD21+ follicular dendritic cell network distinguishes invasive Quilty lesions from cardiac acute cellular rejection. Am J Surg Pathol 30 (2006) 1008-1013
22. McCarthy P.M., Billingham M.E., Flavin T.F., Hunt S.A., and Stinson E.B. Immunosuppression and rejection. In: Smith J.A., Maa M.P., Sarris G.E., Stinson E.B., and Reitz B.A. (Eds). The Stanford Manual of Cardiopulmonary Transplantation (1996), Futura Publishing Co., New York
23. Eisen H.J., Tuzcu E.M., Dorent R., Kobashigawa J., Mancini D., Valantine-von Kaeppler H.A., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
24. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Aurora P., Christie J., et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-Fourth Official Adult Heart Transplant Report-2007. J Heart Lung Transplant 26 (2007) 769-781
25. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Waltz D.A., Keck B.M., et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-Third Official Adult Heart Transplantation Report-2006. J Heart Lung Transplant 25 (2006) 869-879 Epub 2006 Jul 2010
26. Herskowitz A., Soule L.M., Mellits E.D., Traill T.A., Achuff S.C., Reitz B.A., et al. Histologic predictors of acute cardiac rejection in human endomyocardial biopsies: a multivariate analysis. J Am Coll Cardiol 9 (1987) 802-810
27. Termeer C., Averbeck M., Hara H., Eibel H., Herrlich P., Sleeman J., et al. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis. Immunology 109 (2003) 32-40
28. Athanassopoulos P., Vaessen L.M., Balk A.H., Takkenberg J.J., Maat A.P., Weimar W., et al. Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy. Eur J Cardiothorac Surg 27 (2005) 783-789
29. Mach F. Toward a role for statins in immunomodulation. Mol Interv 2 (2002) 478-480
30. Stojanovic I., Vrtovec B., Radovancevic B., Radovancevic R., Yazdanbakhsh A.P., Thomas C.D., et al. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up. J Heart Lung Transplant 24 (2005) 1235-1238
31. Mehra M.R., Uber P.A., Vivekananthan K., Solis S., Scott R.L., Park M.H., et al. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol 40 (2002) 1609-1614
32. Yun J.J., Fischbein M.P., Laks H., Irie Y., Espejo M.L., Fishbein M.C., et al. Rantes production during development of cardiac allograft vasculopathy. Transplantation 71 (2001) 1649-1656
33. Fredrich R., Toyoda M., Czer L.S., Galfayan K., Galera O., Trento A., et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 67 (1999) 385-391
34. Soleimani B., Lechler R.I., Hornick P.I., and George A.J. Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation. Am J Transplant 6 (2006) 1781-1785
35. Mehra M.R., Ventura H.O., Chambers R., Collins T.J., Ramee S.R., Kates M.A., et al. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 26 (1995) 1537-1544
36. Weis M., and von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 96 (1997) 2069-2077
37. De la Fuente M., Baeza I., Guayerbas N., Puerto M., Castillo C., Salazar V., et al. Changes with ageing in several leukocyte functions of male and female rats. Biogerontology 5 (2004) 389-400
38. Krishnaraj R. Negative modulation of human NK cell activity by purinoceptors. 2. Age-associated, gender-specific partial loss of sensitivity to ATP. Cell Immunol 144 (1992) 11-21